Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type 1a (GSD Ia) patients, yet it is unclear how hypoglycemia links to plasma triglyceride (TG) levels. We analyzed whole-body TG metabolism in normoglycemic (fed) and hypoglycemic (fasted) hepatocyte-specific glucose-6-phosphatase deficient (L-G6pc-/- ) mice. De novo fatty acid synthesis contributed substantially to hepatic TG accumulation in normoglycemic L-G6pc-/- mice. In hypoglycemic conditions enhanced adipose tissue lipolysis was the main driver of liver steatosis, supported by elevated free fatty acid concentrations in GSD Ia mice and -patients. Plasma VLDL levels were increased in GSD Ia patients and in normoglycemic L-G6pc-/- mice, and ...
Glycogen storage disease type Ia (GSD Ia) is an inborn error of metabolism caused by defective gluco...
It is a long-standing enigma how glycogen storage disease (GSD) type I patients retain a limited cap...
The Hyplip2 congenic mouse strain contains part of chromosome 15 from MRL/MpJ on the BALB/cJ backgro...
International audiencePrevention of hypertriglyceridemia is one of the biomedical targets in Glycoge...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Glycogen storage disease type 1 (GSD1) is an inborn error of metabolism caused by deficiency of gluc...
Glycogen storage disease type 1a (GSD-1a) is a metabolic disorder characterized by fasting-induced h...
International audienceIt is a long-standing enigma how glycogen storage disease (GSD) type I patient...
The liver secretes triglyceride-rich VLDLs, and the triglycerides in these particles are taken up by...
Congenital generalized lipodystrophy (CGL) is characterized by a complete loss of body adipose tissu...
Glycogen storage disease type Ia (GSD Ia) is an inborn error of metabolism caused by defective gluco...
It is a long-standing enigma how glycogen storage disease (GSD) type I patients retain a limited cap...
The Hyplip2 congenic mouse strain contains part of chromosome 15 from MRL/MpJ on the BALB/cJ backgro...
International audiencePrevention of hypertriglyceridemia is one of the biomedical targets in Glycoge...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Glycogen storage disease type 1 (GSD1) is an inborn error of metabolism caused by deficiency of gluc...
Glycogen storage disease type 1a (GSD-1a) is a metabolic disorder characterized by fasting-induced h...
International audienceIt is a long-standing enigma how glycogen storage disease (GSD) type I patient...
The liver secretes triglyceride-rich VLDLs, and the triglycerides in these particles are taken up by...
Congenital generalized lipodystrophy (CGL) is characterized by a complete loss of body adipose tissu...
Glycogen storage disease type Ia (GSD Ia) is an inborn error of metabolism caused by defective gluco...
It is a long-standing enigma how glycogen storage disease (GSD) type I patients retain a limited cap...
The Hyplip2 congenic mouse strain contains part of chromosome 15 from MRL/MpJ on the BALB/cJ backgro...